MedPath

Pantoprazole sodium

These highlights do not include all the information needed to use PANTOPRAZOLE SODIUM FOR INJECTION safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM FOR INJECTION.  PANTOPRAZOLE SODIUM for injection, for intravenous use  Initial U.S. approval: 2000

Approved
Approval ID

52d5bc28-66df-43aa-bb1a-8ac4a2a7f693

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 16, 2023

Manufacturers
FDA

BE Pharmaceuticals Inc.

DUNS: 081499296

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pantoprazole sodium

PRODUCT DETAILS

NDC Product Code71839-122
Application NumberANDA216171
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateAugust 17, 2023
Generic NamePantoprazole sodium

INGREDIENTS (3)

PANTOPRAZOLE SODIUMActive
Quantity: 40 mg in 10 mL
Code: 6871619Q5X
Classification: ACTIM
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 1 mg in 10 mL
Code: 7FLD91C86K
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pantoprazole sodium - FDA Drug Approval Details